1. Home
  2. CDMO vs NVTS Comparison

CDMO vs NVTS Comparison

Compare CDMO & NVTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDMO
  • NVTS
  • Stock Information
  • Founded
  • CDMO 1981
  • NVTS 2014
  • Country
  • CDMO United States
  • NVTS United States
  • Employees
  • CDMO N/A
  • NVTS N/A
  • Industry
  • CDMO Biotechnology: Pharmaceutical Preparations
  • NVTS Semiconductors
  • Sector
  • CDMO Health Care
  • NVTS Technology
  • Exchange
  • CDMO Nasdaq
  • NVTS Nasdaq
  • Market Cap
  • CDMO 793.8M
  • NVTS 762.1M
  • IPO Year
  • CDMO N/A
  • NVTS N/A
  • Fundamental
  • Price
  • CDMO $12.39
  • NVTS $3.26
  • Analyst Decision
  • CDMO Hold
  • NVTS Buy
  • Analyst Count
  • CDMO 3
  • NVTS 8
  • Target Price
  • CDMO $12.25
  • NVTS $4.75
  • AVG Volume (30 Days)
  • CDMO 1.3M
  • NVTS 6.5M
  • Earning Date
  • CDMO 12-10-2024
  • NVTS 02-27-2025
  • Dividend Yield
  • CDMO N/A
  • NVTS N/A
  • EPS Growth
  • CDMO N/A
  • NVTS N/A
  • EPS
  • CDMO N/A
  • NVTS N/A
  • Revenue
  • CDMO $150,445,000.00
  • NVTS $91,381,000.00
  • Revenue This Year
  • CDMO $19.05
  • NVTS $8.34
  • Revenue Next Year
  • CDMO $20.88
  • NVTS $5.50
  • P/E Ratio
  • CDMO N/A
  • NVTS N/A
  • Revenue Growth
  • CDMO 6.75
  • NVTS 38.99
  • 52 Week Low
  • CDMO $5.90
  • NVTS $1.75
  • 52 Week High
  • CDMO $12.48
  • NVTS $7.40
  • Technical
  • Relative Strength Index (RSI)
  • CDMO 61.55
  • NVTS 47.58
  • Support Level
  • CDMO $12.37
  • NVTS $2.92
  • Resistance Level
  • CDMO $12.45
  • NVTS $3.68
  • Average True Range (ATR)
  • CDMO 0.04
  • NVTS 0.38
  • MACD
  • CDMO -0.02
  • NVTS -0.09
  • Stochastic Oscillator
  • CDMO 71.43
  • NVTS 20.86

About CDMO Avid Bioservices Inc.

Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. Its business is organized into one reportable operating segment which is contract manufacturing and development services segment. Its services include clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The company also provides a variety of process development services including cell line development, upstream and downstream development and optimization, analytical method development, testing and characterization.

About NVTS Navitas Semiconductor Corporation

Navitas Semiconductor Corp develops ultra-efficient gallium nitride (GaN) semiconductors that are revolutionizing power electronics. GaN power ICs integrate GaN power with drive, control, and protection to enable fast charging, high power density, and energy savings for mobile, consumer, enterprise, eMobility, and new energy markets. The company operates as one reportable segment, the design, development, manufacture, and marketing of integrated circuits and related components for use in mobile device and other markets. Geographically, the company operates in China, Europe, United States, Rest of Asia and Others. The majority of revenue is generated from China.

Share on Social Networks: